KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Twist Bioscience (TWST) Consolidated Net Income (2017 - 2026)

Twist Bioscience has reported Consolidated Net Income over the past 10 years, most recently at -$44.0 million for Q1 2026.

  • Quarterly Consolidated Net Income fell 11.86% to -$44.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$81.3 million through Mar 2026, up 57.49% year-over-year, with the annual reading at -$77.7 million for FY2025, 62.8% up from the prior year.
  • Consolidated Net Income was -$44.0 million for Q1 2026 at Twist Bioscience, down from -$30.5 million in the prior quarter.
  • Over five years, Consolidated Net Income peaked at $20.4 million in Q2 2025 and troughed at -$85.6 million in Q2 2024.
  • The 5-year median for Consolidated Net Income is -$44.0 million (2026), against an average of -$43.4 million.
  • Year-over-year, Consolidated Net Income plummeted 59.99% in 2022 and then surged 123.82% in 2025.
  • A 5-year view of Consolidated Net Income shows it stood at -$41.8 million in 2022, then fell by 2.83% to -$43.0 million in 2023, then grew by 26.53% to -$31.6 million in 2024, then increased by 3.45% to -$30.5 million in 2025, then plummeted by 44.3% to -$44.0 million in 2026.
  • Per Business Quant, the three most recent readings for TWST's Consolidated Net Income are -$44.0 million (Q1 2026), -$30.5 million (Q4 2025), and -$27.1 million (Q3 2025).